Bill Haack

Mr. Haack has over 20 years of experience in life sciences. He started his career at Genentech where he led the Sales Operations team and the successful launch of Rituxan and Herceptin. He was an early employee at Genomic Health where he helped lead and was instrumental in the success of the launch and commercial success of all three Oncotype DX products. Under Mr. Haack’s leadership, Genomic Health grew from a company with no revenue to over $300M in annual revenues. Mr. Haack also led the launch of Genomic Health in Europe where he led the start-up of their headquarters in Geneva and the establishment of commercial teams in the United Kingdom, France, Italy and Germany. Mr. Haack holds an MA degree in Economics and Econometrics.